PRESS RELEASE published on 04/10/2025 at 15:58, 1 year 1 month ago Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe SCHOTT Pharma opens new production facility in Serbia to strengthen competitiveness in Europe, creating 180 new jobs and increasing ampoule manufacturing capacity SCHOTT Pharma Competitiveness Serbia Production Facility Ampoule Manufacturing
BRIEF published on 02/13/2025 at 07:05, 1 year 3 months ago SCHOTT Pharma Begins Fiscal Year 2025 with Promising Results Revenue Growth EBITDA Margin Q1 Results High-value Solutions DCS Segment
BRIEF published on 02/13/2025 at 07:05, 1 year 3 months ago SCHOTT Pharma débute l'année fiscale 2025 avec des résultats prometteurs Marge EBITDA Croissance Des Revenus Résultats Du Premier Trimestre Des Solutions À Haute Valeur Ajoutée Segment DCS
PRESS RELEASE published on 02/13/2025 at 07:00, 1 year 3 months ago SCHOTT Pharma records good start into fiscal year and confirms full year outlook SCHOTT Pharma reports good start in Q1 2025 with EUR 230m revenues, confirms full year outlook. EBITDA margin at 25.1% as reported. High-value solutions share at 55% Revenues EBITDA Margin SCHOTT Pharma Full Year Outlook Q1 2025
BRIEF published on 02/04/2025 at 18:27, 1 year 3 months ago SCHOTT Pharma Holds Successful Annual General Meeting Annual General Meeting Shareholder Approval SCHOTT Pharma Profit Growth MDAX Promotion
BRIEF published on 02/04/2025 at 18:27, 1 year 3 months ago SCHOTT Pharma organise avec succès son assemblée générale annuelle SCHOTT Pharma Assemblée Générale Annuelle Approbation Des Actionnaires Croissance Des Bénéfices Promotion MDAX
PRESS RELEASE published on 02/04/2025 at 18:22, 1 year 3 months ago SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items SCHOTT Pharma's successful Annual General Meeting for FY 2024 with all agenda items approved by shareholders, including new Supervisory Board member Dr. Wolfram Carius and KPMG as new auditor Annual General Meeting Shareholders SCHOTT Pharma KPMG Dr. Wolfram Carius
BRIEF published on 12/12/2024 at 07:05, 1 year 5 months ago SCHOTT Pharma Reports Strong Growth and Record Margins for FY 2024 Revenue Growth EBITDA Margin High-value Solutions Drug Delivery Systems Innovation And Expansion
BRIEF published on 12/12/2024 at 07:05, 1 year 5 months ago SCHOTT Pharma annonce une forte croissance et des marges record pour l'exercice 2024 Marge EBITDA Croissance Des Revenus Systèmes D'administration De Médicaments Des Solutions À Haute Valeur Ajoutée Innovation Et Expansion
PRESS RELEASE published on 12/12/2024 at 07:00, 1 year 5 months ago SCHOTT Pharma with strong growth and record margin after solid year-end finish SCHOTT Pharma AG & Co. KGaA reports strong growth and record margin for the fiscal year 2024, meeting 12% revenue growth target and achieving EBITDA margin of 27.8% Innovation Revenue EBITDA Margin SCHOTT Pharma Growth
Published on 05/13/2026 at 23:30, 2 hours 15 minutes ago CCL Industries Announces Results for 2026 First Quarter
Published on 05/13/2026 at 23:15, 2 hours 30 minutes ago Avino Delivers Record Q1 2026 Financial Results
Published on 05/13/2026 at 23:05, 2 hours 40 minutes ago Vox Royalty Reports Record Q1 2026 Results, Increases 2026 Guidance and Declares Quarterly Dividend
Published on 05/13/2026 at 22:30, 3 hours 15 minutes ago Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure
Published on 05/14/2026 at 01:05, 39 minutes ago THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 22:20, 3 hours 24 minutes ago Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:18, 5 hours 26 minutes ago EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 19:28, 6 hours 16 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/13/2026 at 18:02, 7 hours 42 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 7 hours 45 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 8 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
